Traditional Chinese medicinal liquid agent for treating chronic prostatitis

A technology of chronic prostatitis and traditional Chinese medicine, which is applied in the direction of medical preparations containing active ingredients, drug combinations, and pharmaceutical formulas, which can solve the problems of large side effects of antibiotics and unsatisfactory effects of chronic prostatitis, and improve intestinal contraction , Enhance the effect of promoting blood circulation and labor pain

Inactive Publication Date: 2008-04-30
张金刚
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Chronic prostatitis is a common disease of the male genitourinary system. Due to the "barrier" of the prostate capsule, it is difficult for the antibiotics currently used to enter the acinus to play a rol

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0007] Example 1: Take 30 grams of rhubarb, 5 grams of Panax notoginseng, 25 grams of Polygonum cuspidatum, 25 grams of dandelion, 12 grams of frankincense, 12 grams of myrrh, 15 grams of diding, 12 grams of Achyranthes bidentata, 10 grams of peach kernel, and add 1000 grams of water to the above raw materials. Milliliters, after boiling with strong fire, heat with slow fire for about 1 hour, extract 200-300 ml of liquid medicine, cool to about 40 degrees for later use.

Embodiment 2

[0008] Example 2: Take 28 grams of rhubarb, 5 grams of Panax notoginseng, 22 grams of Polygonum cuspidatum, 25 grams of dandelion, 12 grams of frankincense, 12 grams of myrrh, 15 grams of diding, 12 grams of Achyranthes bidentata, 10 grams of peach kernel, 10 grams of pangolin, curcuma 10 grams, Verbena 15 grams. Add 1000 ml of water to the above-mentioned raw materials, bring to a boil with strong fire, then heat with slow fire for about 1 hour, extract 200-300 ml of liquid medicine, and cool to about 40 degrees for later use.

[0009] The using method of this medicinal liquid is: the patient empties the two stools. Lying on the side, insert a disposable catheter 7-10 cm into the anus, then inject 100-200 ml of liquid medicine with a 50-ml syringe, and pull out the catheter. The liquid flows out. The treatment adopts traditional Chinese medicine enema. Since the medicine directly acts on the rectum and is close to the lesion, the prostate can directly absorb the medicine, t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an externally used traditional Chinese medicine liquid medicament for curing chronic prostatitis in the field of the traditional Chinese medicine medicaments. The technical proposal is that the invention comprises the traditional Chinese medicines with the weight parts of rhubarb 28-35, notoginseng 4-6, giant knotweed rhizome 20-30, dandelion 25-30, mastic 10-15, myrrh 10-15, corydalis bungeana turcz 10-18, achyranthes 0-15, and peach kernel 8-12, wherein the raw medicament is charged with the 800-1200 weight parts of water, and then the medicament fluid 200-300 weight parts are decocted and extracted. The proposal also comprises the raw materials of the traditional Chinese medicine with the weight parts of pangolin 8-12, curcuma zedoaria rose 8-12, and verbena 10-15. The externally used traditional Chinese medicine liquid medicament for curing chronic prostatitis has the advantages of the direct curative effect, and the convenient and easy operation without obvious toxic and side effects. After 1080 examples of the clinical application certification, the cure rate of the invention reaches 92%, and the total effective rate reaches 98%.

Description

technical field [0001] The invention relates to an external Chinese medicine liquid for treating chronic prostatitis in the field of traditional Chinese medicine preparations. Background technique [0002] Chronic prostatitis is a common disease of the male genitourinary system. Due to the "barrier" of the prostate capsule, it is difficult for the currently used antibiotics to enter the acinus and play a role. In addition to factors such as bacterial resistance, antibiotics are used alone for treatment The effect of chronic prostatitis is not ideal. In addition, the use of antibiotics itself has great side effects. Contents of the invention [0003] The object of the present invention is to aim at the defects in the prior art, and provide an external Chinese medicine liquid for treating chronic prostatitis with direct curative effect, easy operation and no obvious side effects. [0004] The technical scheme is: comprising the following traditional Chinese medicine raw ma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/86A61P13/08A61K35/36
Inventor 张金刚桓树学周淑丽李洪福赵光华
Owner 张金刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap